TROV Key Statistics, Chart & Performance
The current stock price of TROV is 1.19 null. In the past month the price increased by 47.08%. In the past year, price decreased by -62.34%.
TROV Latest News, Press Relases and Analysis
About TROV
Company Profile
Trovagene is a clinical-stage, oncology therapeutics company, taking a precision cancer medicine approach to develop drugs that target mitosis (cell division) to treat various types of cancer, including leukemias, lymphomas and solid tumors. Trovagene has intellectual property and proprietary technology that enables the Company to analyze circulating tumor DNA (ctDNA) and clinically actionable markers to identify patients most likely to respond to specific cancer therapies. Trovagene plans to continue to vertically integrate its tumor genomics technology with the development of targeted cancer therapeutics.
Company Info
Trovagene Inc
11055 FLINTKOTE AVENUE
SAN DIEGO CA 92121
CEO: Thomas H. Adams
Phone: 858-952-7570
Trovagene Inc / TROV FAQ
Can you describe the business of Trovagene Inc?
Trovagene is a clinical-stage, oncology therapeutics company, taking a precision cancer medicine approach to develop drugs that target mitosis (cell division) to treat various types of cancer, including leukemias, lymphomas and solid tumors. Trovagene has intellectual property and proprietary technology that enables the Company to analyze circulating tumor DNA (ctDNA) and clinically actionable markers to identify patients most likely to respond to specific cancer therapies. Trovagene plans to continue to vertically integrate its tumor genomics technology with the development of targeted cancer therapeutics.
What is the current price of TROV stock?
The current stock price of TROV is 1.19 null. The price decreased by -0.83% in the last trading session.
Does TROV stock pay dividends?
TROV does not pay a dividend.
What is the ChartMill technical and fundamental rating of TROV stock?
TROV has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Should I buy TROV stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on TROV.
Can you provide the ownership details for TROV stock?
You can find the ownership structure of Trovagene Inc (TROV) on the Ownership tab.
TROV Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to TROV. When comparing the yearly performance of all stocks, TROV is a bad performer in the overall market: 85.67% of all stocks are doing better.
TROV Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TROV. TROV may be in some trouble as it scores bad on both profitability and health.
TROV Financial Highlights
Over the last trailing twelve months TROV reported a non-GAAP Earnings per Share(EPS) of -2.8. The EPS increased by 66.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -4732.65% | ||
| ROA | -140.47% | ||
| ROE | N/A | ||
| Debt/Equity | 0.11 |